Login / Signup

Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer.

Luis D Borrero-GarcíaMaria Del Mar MaldonadoJulia Medina-VelázquezAngel L Troche-TorresLuis VelazquezNilmary Grafals-RuizSuranganie Dharmawardhane
Published in: BMC cancer (2021)
Rac inhibition may represent a viable strategy for treatment of EGFR/HER2 targeted therapy resistant breast cancer.
Keyphrases
  • small cell lung cancer
  • epidermal growth factor receptor
  • tyrosine kinase
  • cell migration
  • combination therapy
  • replacement therapy
  • childhood cancer